19 November

Sticky

Weekly Copyright News: Publication of Bare Acts Not Infringement, Cinematograph Act Amendments, No Copyright For Taste, and More

in Copyrights, Intellectual Property, Media and Entertainment Law, Publicity Rights, Publicity Rights/ Celebrity Rights

Copyright Quote “Is settling with the pirate a new option to manage/control large-scale copyright infringement? Isn’t joining hands with pirates the wrong precedent?” Dr. Kalyan C Kankanala Copyright Statistics There is a decrease of 62% in the total number of copyright applications filed last week as compared to the previous week. A total of 146 applications were filed for copyright registration during the last week. The majority of applications were filed for literary works and artistic works. S. No Type of Work Number of Applications filed in the Previous Week (29th October 2018 to 04th November, 2018) Number of Applications filed in the Recent Week (05th November 2018 to 11th November,...

19 November

0 Comments

Sticky

Weekly Patent News: New patent policy in India? Interesting Patents, L’Oréal vesrus Drunk Elephant, No patent settlement talks for Qualcomm and Apple, No patent for Pfizer’s Pregablin says Supreme Court and more

Posted by BIP Patent Attorneys

in Intellectual Property, Patents

“Indian patent statistics, Interesting inventions, DIPP Secretary states that a new Industrial Policy will soon be in place, L’Oréal sues Drunk Elephant, UK Supreme Court dismisses Pfizer's patent claim on pregabalin, Apple versus Qualcomm - No Settlement Talks are on, IP Awareness Summit (IPAS), 2018 to be hosted by CIPU, in late November, EPO hosts the 28th Annual Patent Information Conference in Brussels and other Weekly Patent News updates,” presented by the Patent attorneys and experts of BananaIP Counsels, India’s leading Patent Firm. Design Quote of the Week "Design is thinking made visual.” – Saul Bass, American graphic designer and Academy Award winning filmmaker, best known...

14 November

0 Comments

Sticky

Weekly Trademark News: Mickey Mouse Meets Crocodile, Morgan Stanley Tussle, West Bengal‘s Rosogolla Day and other news

Posted by BananaIP Trademark Attorneys

in Intellectual Property, Trademarks

Indian Trademark Statistics for November (Second Week) 2018, Big Win for Nintendo, Shoppers Stop Stops Infringement, West Bengal to Celebrate ‘Rosogolla Day’ and more, brought to you by the Trademark Attorneys at BananaIP (BIP) Counsels. TRADEMARK QUOTE OF THE WEEK “Every advertisement should be thought of as a contribution to the complex symbol which is the brand image" – David Ogilvy INDIAN TRADEMARK STATISTICS The Indian Trademark Office has been slow in the last week due. The total number of the applications disposed through show cause hearings has decreased by thirty one percent (31%). Similarly, the total number of applications examined by the...

13 November

0 Comments

Sticky

Circumventing Around Anti-circumvention Law

Posted by BananaIP Reporter

in Copyrights, Intellectual Property, Media and Entertainment Law

This post was first published on May 6, 2010. Copyright law protects works of authorship by granting a bundle of rights. The rights of an author with respect to a work extend to the expression of the work in any manner including in digital or electronic form. Though works in digital form provide great advantages to the copyright owner by reducing the cost and effort of reproduction and distribution, safeguarding unauthorized copying and transfer of the work is very challenging. In order to avoid use of works by a third party without permission, most copyright owners use technological measures such as encryption,...

12 November

0 Comments

Sticky

Filing Design Applications in India

Posted by BIP Patent Attorneys

in Industrial Designs

The featured image shows a coca cola bottle famous for the design of its bottle.

Design can be broadly described as the outer appearance or the shape of an article visible to the naked eye. In India and in most other parts of the world, a new and distinct design can be conferred Intellectual property protection as an Industrial design, provided it fulfills the parameters that have been laid down by the law for such protection. Industrial Design protection is limited to only the aesthetic appearance of an article and does not extend to its functionality. Design is defined under Section 2(d) of Indian Designs Act, 2000 as "features of shape and configuration, ornamentation, pattern or...

12 November

0 Comments

Sticky

Weekly Patent News: Interesting Patents, IIT-M to host Tech summit, Cannabis Patent, Qualcomm forced to license its patents, Canada becomes party to Hague Agreement, USPTO’s new Sponsorship Tool and more

Posted by BananaIP Reporter

in Intellectual Property, Patents

“Indian patent statistics, Interesting inventions, IIT Madras to host Shaastra Summit, Qualcomm forced to license its patents to rivals, USPTO’s new Sponsorship Tool to give other members access to the Patent Electronic System, USPTO grants a patent to a composition containing Cannabis and other Weekly Patent News updates,” presented by the Patent attorneys and experts of BananaIP Counsels, India’s leading Patent Firm. Design Quote of the Week "Design is the silent ambassador of your brand.” – Paul Rand, American art director and graphic designer, best known for his corporate logo designs, including the logos for IBM, UPS, Enron, Morningstar, Inc. Indian Patent Statistics A...

11 November

1 Comment

Sticky

Rejection of application based on pre-grant representation may be appealed to IPAB

Posted by BananaIP Reporter

in Intellectual Property, Patents

First Publication Date: 10th February 2010 In a decision delivered on February 8th, 2010, the Delhi High Court held that an applicant aggrieved by the rejection of his application by the Controller based on a pre-grant representation may file an appeal to the Intellectual Property Appellate Board (IPAB). The court delivered the decision after consolidating writ petitions filed by UCB FARCHIM, COLORCON, YEDA RESEARCH & DEVELOPMENT and ELI LILLY. As per the Court, a rejection by the Controller based on a pre-grant representation under Section 25(1) would be a decision under Section 15 of the Patents Act and therefore may be...

10 November

1 Comment

Sticky

What should I do with my invention before I talk to Venture Capitalists?

Posted by BananaIP Reporter

in Intellectual Property, Patents

First Publication Date: 9th February 2010 Every now and then I come across this question, and most often it’s asked by individual inventors and start-ups. In most cases, when you invent something, the next logical step would be to raise funds and build a business around it. To raise funds you will have to disclose the idea/invention to several VCs, preferable after signing a non disclosure agreement (NDA). A NDA, in brief, is a legal instrument that binds the parties entering into the agreement to maintain confidentiality of the information that is disclosed. However, from what I have heard, making a...

09 November

0 Comments

Sticky

Pharmaceutical business strategy – A Brand name perspective.

Posted by BananaIP Reporter

in Intellectual Property, Patents

First Publication Date: 9th February 2010 In furtherance to Vikram’s post on Paragraph IV certification and its exploitation by generic pharmaceutical companies (ANDA applicant) to enter the market sooner, here is an insight on the NDA holders’ attempt to exploit the same. Every ANDA application filed by a generic company has to be in a prescribed format and must contain the prescribed content as per 21CFR sec. 314.94 (Contents and Format of an Abbreviated application). Each of these applications will refer to a Reference listed drug (RLD) and the use of such drug by the company in order to get approval for...

09 November

3 Comments

Sticky

Pharmaceutical business strategy – A generics perspective

Posted by BananaIP Reporter

in Intellectual Property, Patents

First Publication Date: 29th January 2010 One of strategies prevalent in the pharmaceutical sector is to invest in research through which new chemical entities and new products can be invented which will help to challenge the existing patents successfully. However, with the amount of money involved in this kind of strategy, a lot of other strategies have emerged by which pharmaceutical companies mainly generics do business, one of which are challenges of patents under Para IV of the Hatch Waxman Act, 1984 (hereinafter referred to as the “Act”). Whenever a new drug is to to be released in the market, the innovator...

Intellepedia – IP News Center

SOME OF OUR CLIENTS